Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure

被引:158
作者
Juraschek, Stephen P. [1 ,2 ,3 ]
Miller, Edgar R., III [2 ,3 ]
Weaver, Connie M. [4 ]
Appel, Lawrence J. [2 ,3 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[4] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
blood pressure; DASH; diet; sodium; trial; PATTERNS; METAANALYSIS; TRIAL; TIME;
D O I
10.1016/j.jacc.2017.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Both sodium reduction and the DASH (Dietary Approaches to Stop Hypertension) diet, a diet rich in fruits, vegetables, and low-fat dairy products, and reduced in saturated fat and cholesterol, lower blood pressure. The separate and combined effects of these dietary interventions by baseline blood pressure (BP) has not been reported. OBJECTIVES The authors compared the effects of low versus high sodium, DASH versus control, and both (low sodium-DASH vs. high sodium-control diets) on systolic blood pressure (SBP) by baseline BP. METHODS In the DASH-Sodium (Dietary Patterns, Sodium Intake and Blood Pressure) trial, adults with pre- or stage 1 hypertension and not using antihypertensive medications, were randomized to either DASH or a control diet. On either diet, participants were fed each of 3 sodium levels (50, 100, and 150 mmol/day at 2,100 kcal) in random order over 4 weeks separated by 5-day breaks. Strata of baseline SBP were < 130, 130 to 139, 140 to 149, and $ 150 mm Hg. RESULTS Of 412 participants, 57% were women, and 57% were black; mean age was 48 years, and mean SBP/diastolic BP was 135/86 mm Hg. In the context of the control diet, reducing sodium (from high to low) was associated with mean SBP differences of -3.20, -8.56, -8.99, and -7.04 mm Hg across the respective baseline SBP strata listed (p for trend =0.004). In the context of high sodium, consuming the DASH compared with the control diet was associated with mean SBP differences of -4.5, -4.3, -4.7, and -10.6 mm Hg, respectively (p for trend -0.66). The combined effects of the low sodium-DASH diet versus the high sodium-control diet on SBP were -5.3, -7.5, -9.7, and -20.8 mm Hg, respectively (p for trend < 0.001). CONCLUSIONS The combination of reduced sodium intake and the DASH diet lowered SBP throughout the range of pre-and stage 1 hypertension, with progressively greater reductions at higher levels of baseline SBP. SBP reductions in adults with the highest levels of SBP ($ 150 mm Hg) were striking and reinforce the importance of both sodium reduction and the DASH diet in this high-risk group. Further research is needed to determine the effects of these interventions among adults with SBP $ 160 mm Hg. (Dietary Patterns, Sodium Intake and Blood Pressure [DASH-Sodium]; (C) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:2841 / 2848
页数:8
相关论文
共 50 条
  • [1] Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet
    Juraschek, Stephen P.
    Woodward, Mark
    Sacks, Frank M.
    Carey, Vincent J.
    Miller, Edgar R., III
    Appel, Lawrence J.
    HYPERTENSION, 2017, 70 (05) : 923 - +
  • [2] Effects of Sodium Reduction and the DASH Diet by Level of Baseline Blood Pressure: Pronounced Benefits Among Adults With Higher Blood Pressure
    Juraschek, Stephen P.
    Miller, Edgar R.
    Weaver, Connie M.
    Appel, Lawrence J.
    CIRCULATION, 2017, 136
  • [3] Time Course of Change in Blood Pressure From the DASH Diet and Sodium Reduction
    Juraschek, Stephen P.
    Woodward, Mark
    Sacks, Frank M.
    Carey, Vincent J.
    Miller, Edgar R.
    Appel, Larry J.
    CIRCULATION, 2017, 135
  • [4] Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation The DASH-Sodium Trial
    Juraschek, Stephen P.
    Kovell, Lara C.
    Appel, Lawrence J.
    Miller, Edgar R., III
    Sacks, Frank M.
    Chang, Alex R.
    Christenson, Robert H.
    Rebuck, Heather
    Mukamal, Kenneth J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 77 (21) : 2625 - 2634
  • [5] Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions
    Kim, Hyunju
    Appel, Lawrence J.
    Lichtenstein, Alice H.
    Wong, Kari E.
    Chatterjee, Nilanjan
    Rhee, Eugene P.
    Rebholz, Casey M.
    HYPERTENSION, 2023, 80 (07) : 1494 - 1506
  • [6] Overview of salt restriction in the Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean diet for blood pressure reduction
    Filippou, Christina
    Tatakis, Fotis
    Polyzos, Dimitrios
    Manta, Eleni
    Thomopoulos, Costas
    Nihoyannopoulos, Petros
    Tousoulis, Dimitrios
    Tsioufis, Konstantinos
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (01)
  • [7] Effect of sodium reduction based on the DASH diet on blood pressure in hypertensive patients with type 2 diabetes
    Mu, Lisha
    Yu, Pingping
    Xu, Huini
    Gong, Tao
    Chen, Dan
    Tang, Jie
    Zou, Yujia
    Rao, Huakun
    Mei, Ying
    Mu, Lihong
    NUTRICION HOSPITALARIA, 2022, 39 (03) : 537 - 546
  • [8] Ambulatory blood pressure in the dash diet trial: Effects of race and albuminuria
    Tyson, Crystal C.
    Barnhart, Huiman
    Sapp, Shelly
    Poon, Victor
    Lin, Pao-Hwa
    Svetkey, Laura P.
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (02) : 308 - 314
  • [9] Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Filippou, Christina D.
    Tsioufis, Costas P.
    Thomopoulos, Costas G.
    Mihas, Costas C.
    Dimitriadis, Kyriakos S.
    Sotiropoulou, Lida, I
    Chrysochoou, Christina
    Nihoyannopoulos, Petros, I
    Tousoulis, Dimitrios M.
    ADVANCES IN NUTRITION, 2020, 11 (05) : 1150 - 1160
  • [10] Effects of the DASH diet on blood pressure in patients with and without metabolic syndrome: results from the DASH trial
    Fadi Hikmat
    L J Appel
    Journal of Human Hypertension, 2014, 28 : 170 - 175